Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1997 3
1998 2
2000 2
2001 2
2002 2
2004 3
2005 6
2006 2
2007 4
2008 9
2009 4
2010 8
2011 10
2012 6
2013 8
2014 10
2015 19
2016 15
2017 18
2018 17
2019 13
2020 16
2021 23
2022 20
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Uterine Carcinosarcomas.
Sagebiel TL, Bhosale PR, Patnana M, Faria SC, Devine CE. Sagebiel TL, et al. Semin Ultrasound CT MR. 2019 Aug;40(4):295-301. doi: 10.1053/j.sult.2019.03.004. Epub 2019 Mar 9. Semin Ultrasound CT MR. 2019. PMID: 31375170 Review.
This article reviews the epidemiology, pathologic classification and staging of UCS, along with the typical findings seen on different imaging modalities. Prognosis and therapies will also be discussed....
This article reviews the epidemiology, pathologic classification and staging of UCS, along with the typical findings seen on different imagi …
Uterine sarcomas.
Ganjoo KN. Ganjoo KN. Curr Probl Cancer. 2019 Aug;43(4):283-288. doi: 10.1016/j.currproblcancer.2019.06.001. Epub 2019 Jun 14. Curr Probl Cancer. 2019. PMID: 31235185 Review.
Uterine carcinosarcoma.
Arend R, Doneza JA, Wright JD. Arend R, et al. Curr Opin Oncol. 2011 Sep;23(5):531-6. doi: 10.1097/CCO.0b013e328349a45b. Curr Opin Oncol. 2011. PMID: 21743326 Review.
RECENT FINDINGS: Recent studies have suggested that uterine carcinosarcomas are aggressive neoplasms that carry a poor prognosis even when diagnosed at an early stage. Treatment is typically surgical. ...
RECENT FINDINGS: Recent studies have suggested that uterine carcinosarcomas are aggressive neoplasms that carry a poor prognosis even …
Uterine carcinosarcoma: An overview.
Pezzicoli G, Moscaritolo F, Silvestris E, Silvestris F, Cormio G, Porta C, D'Oronzo S. Pezzicoli G, et al. Crit Rev Oncol Hematol. 2021 Jul;163:103369. doi: 10.1016/j.critrevonc.2021.103369. Epub 2021 May 27. Crit Rev Oncol Hematol. 2021. PMID: 34051304 Review.
Uterine carcinosarcoma (UCS), also known as malignant mixed Mullerian tumor, is a rare gynecological malignancy characterized by poor prognosis. This "biphasic" neoplasm presents an admixture of epithelial and mesenchymal/sarcomatoid tumor cells which partially share their …
Uterine carcinosarcoma (UCS), also known as malignant mixed Mullerian tumor, is a rare gynecological malignancy characterized by poor pro …
Adjuvant therapy and prognosis in uterine carcinosarcoma.
Chiang CY, Huang HJ, Chang WY, Yang LY, Wu RC, Wang CC, Tung HJ, Chao A, Lai CH. Chiang CY, et al. J Formos Med Assoc. 2021 Nov;120(11):1977-1987. doi: 10.1016/j.jfma.2021.04.016. Epub 2021 May 13. J Formos Med Assoc. 2021. PMID: 33992491 Free article.
PURPOSE: To investigate the prognostic factors and impact of adjuvant treatment on uterine carcinosarcoma (UCS). ...Multivariate stepwise Cox proportional hazard regression models were used to identify the independent predictors of overall survival (OS) and progress …
PURPOSE: To investigate the prognostic factors and impact of adjuvant treatment on uterine carcinosarcoma (UCS). ...Multivariate step …
Uterine Carcinosarcomas - Diagnosis and Management.
Denschlag D, Ulrich UA. Denschlag D, et al. Oncol Res Treat. 2018;41(11):675-679. doi: 10.1159/000494335. Epub 2018 Oct 13. Oncol Res Treat. 2018. PMID: 30317231 Review.
Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A, Nishikawa T, Yoshida H, Mizoguchi C, Kitadai R, Yamamoto K, Yazaki S, Kojima Y, Ishikawa M, Kato T, Yonemori K. Saito A, et al. Gynecol Oncol. 2023 Sep;176:115-121. doi: 10.1016/j.ygyno.2023.07.010. Epub 2023 Jul 26. Gynecol Oncol. 2023. PMID: 37506533
However, in uterine carcinosarcoma, no significant relationship was observed between FRalpha expression and clinicopathological features or prognosis....
However, in uterine carcinosarcoma, no significant relationship was observed between FRalpha expression and clinicopathological features or …
Adjuvant chemotherapy in endometrial cancer.
Gómez-Raposo C, Merino Salvador M, Aguayo Zamora C, Casado Saenz E. Gómez-Raposo C, et al. Cancer Chemother Pharmacol. 2020 Mar;85(3):477-486. doi: 10.1007/s00280-019-04027-6. Epub 2020 Jan 16. Cancer Chemother Pharmacol. 2020. PMID: 31950214 Review.
The treatment of EC following surgical staging is based on the risk of relapse, which is defined by the cancer stage at diagnosis, histology of the tumor and other prognostic factors such as grade differentiation, the presence of substantial lymphovascular invasion (LVSI), …
The treatment of EC following surgical staging is based on the risk of relapse, which is defined by the cancer stage at diagnosis, histology …
Review literature on uterine carcinosarcoma.
Singh R. Singh R. J Cancer Res Ther. 2014 Jul-Sep;10(3):461-8. doi: 10.4103/0973-1482.138197. J Cancer Res Ther. 2014. PMID: 25313723 Free article. Review.
Traditionally this tumour has been regarded as a subtype of uterine sarcoma, and its origin remains controversial. The exact nature and prognosis was not clear in the past. It is believed that uterine carcinosarcoma have a Mullerian duct origin and have a capacity to diffe …
Traditionally this tumour has been regarded as a subtype of uterine sarcoma, and its origin remains controversial. The exact nature and p …
211 results